Tumor extracts were incubated at 37°C overnight with 0.5 mM 6-3 H-labeled 5-fluorocytosine (7.6 Ci/mmol). The reaction was terminated by the addition of 1 M acetic acid. The produced 3 H-labeled ...

A randomized phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET). This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not ...

02 October 2019 As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of vocimagene amiretrorepvec with extended-release ...

The study compares a cancer-selective virus, Toca 511 (vocimagene amiretrorepvec), in combination with Toca FC (extended-release 5-fluorocytosine), to standard of care in patients with first or ...